These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9289806)

  • 41. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F; Plauth M
    Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of active Crohn's disease with an oral slow-release budesonide formulation.
    Roth M; Gross V; Schölmerich J; Ueberschaer B; Ewe K
    Am J Gastroenterol; 1993 Jun; 88(6):968-9. PubMed ID: 8503403
    [No Abstract]   [Full Text] [Related]  

  • 44. New treatments in inflammatory bowel disease.
    Cole AT; Hawkey CJ
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):581-90. PubMed ID: 1591558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of cytomegalovirus infection in inflammatory bowel diseases.
    Pillet S; Pozzetto B; Jarlot C; Paul S; Roblin X
    Dig Liver Dis; 2012 Jul; 44(7):541-8. PubMed ID: 22538204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease.
    Zimmerman MJ; Jewell DP
    Aliment Pharmacol Ther; 1996; 10 Suppl 2():93-8; discussion 99. PubMed ID: 8899107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Advances in the topical steroid treatment of inflammatory bowel diseases].
    Díaz Blasco J; Robledo Andrés P
    Rev Esp Enferm Dig; 1995 Nov; 87(11):802-7. PubMed ID: 8534536
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of inflammatory bowel disease (IBD).
    Pithadia AB; Jain S
    Pharmacol Rep; 2011; 63(3):629-42. PubMed ID: 21857074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Methotrexate in therapy of chronic inflammatory bowel diseases].
    Schröder O; Stein J
    Z Gastroenterol; 1996 Jul; 34(7):457-8. PubMed ID: 8928541
    [No Abstract]   [Full Text] [Related]  

  • 50. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.
    de Mattos BR; Garcia MP; Nogueira JB; Paiatto LN; Albuquerque CG; Souza CL; Fernandes LG; Tamashiro WM; Simioni PU
    Mediators Inflamm; 2015; 2015():493012. PubMed ID: 26339135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.
    Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C
    Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunocorrective therapy of chronic nonspecific inflammatory diseases of the intestines (a review of the literature)].
    Tkach SM; Bychkova NG; Blazhenko IL
    Vrach Delo; 1989 Sep; (9):58-62. PubMed ID: 2692295
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease.
    Klotz U
    Eur J Clin Pharmacol; 2000 Aug; 56(5):353-62. PubMed ID: 11009042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Budesonide in inflammatory bowel disease.
    Lamers CB; Wagtmans MJ; van der Sluys Veer A; van Hogezand RA; Griffioen G
    Neth J Med; 1996 Feb; 48(2):60-3. PubMed ID: 8819801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucocorticoids in pediatric inflammatory bowel disease.
    Sidoroff M; Kolho KL
    Scand J Gastroenterol; 2012 Jul; 47(7):745-50. PubMed ID: 22507033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Locally acting glucocorticoids in chronic intestinal inflammation].
    Lamers CB; van der Sluys Veer A; Wagtmans MJ; van Hogezand RA
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2533-5. PubMed ID: 7830800
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunological apparatus of the gut and inflammatory bowel disease.
    Kraft SC; Kirsner JB
    Gastroenterology; 1971 May; 60(5):922-51. PubMed ID: 4931956
    [No Abstract]   [Full Text] [Related]  

  • 58. Understanding the use of immunosuppressive agents in the clinical management of IBD.
    Waters OR; Lawrance IC
    Curr Drug Targets; 2011 Aug; 12(9):1364-71. PubMed ID: 21291384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled-release budesonide in Crohn's disease.
    Drug Ther Bull; 1997 Apr; 35(4):30-1. PubMed ID: 9282408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
    Campieri M
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III43-6. PubMed ID: 11953332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.